Genprex Announces Registered Direct Offering of up to $8.1 Million Priced At-The-Market Under Nasdaq Rules
October 23, 2025
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022
February 14, 2022
Related Post
-
-
Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance
October 16, 2025
-
Dominari Securities Raises Over $1.4 Billion Year-to-Date in Support of American Innovation and Entrepreneurship
October 16, 2025
-
Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
October 10, 2025